Science News
The skin is not merely a protective barrier; it is a complex, dynamic ecosystem populated by billions of microorganisms that play essential roles in maintaining skin health.
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
A new database of thousands of gut microbiota samples from across the word highlights the need for more diverse microbiota research across the globe.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
David Paez-Espino, Co-founder & CTO at Ancilia Biosciences, discusses the use of CRISPR technology to develop a new class of bacterial therapies that address critical gaps in microbiome-based treatments.
Researchers have developed a new approach to restore the gut microbiota by combining a high-fiber, plant-based diet with supplementation of beneficial microbes such as Limosilactobacillus reuteri.
The microbiota plays a protective role against colorectal cancer by regulating Snhg9.
Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.
Chris Ford, Senior Vice President, Translational Biology at Seres Therapeutics, discusses the development of SER-155, a cultivated bacterial consortium designed to address the unmet medical need of preventing bloodstream infections…
By suggesting that BA–MCYs can regulate the production of bile acids, the findings of a recent study offer insights for treating metabolic conditions such as diabetes.
Specific microbial metabolites can lead to new therapies for skin barrier disorders such as eczema and psoriasis.
A comprehensive look at the gut microbiome’s structure, functions, and strategies for sustaining its health.
The discussion with Professor Alessio Fasano highlights the complex interplay between homeostatic, hedonic, and microbiota-driven mechanisms in regulating hunger.
Chemical biology offers useful methods to study microbial systems and gather molecular information about microbiomes.
Probiotics such as Lactobacillus can complement breast cancer therapy to improve prevention and treatment.
Fecal Microbiota Transplantation (FMT) showing promise beyond C. difficile infection in conditions like IBD, IBS, and metabolic disorders.
Celine Druart, from the Pharmabiotic Research Institute, highlighted critical challenges in the microbiome field, particularly around the standardization of clinical protocols and analytical methods.
High levels of bile acids drive bacterial colonization of the gut and exacerbate gut inflammation by altering the intestinal environment.
The effects of coffee on health may be mediated by gut microbes such as L. asaccharolyticus and their metabolites.
Nigel Titford, CEO at Biogaia Pharma, discusses the strategic considerations and challenges involved in working across both the dietary supplement and pharmaceutical sectors.
